Login / Signup

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Laura ZanandreaRoberta MessinaIlaria CettaFederica GenoveseSimone GuerrieriFabrizio VernieriClaudia AltamuraSabina CevoliValentina FavoniBruno ColomboMassimo Filippi
Published in: European journal of neurology (2024)
Both monthly and quarterly regimens were effective and safe, with a tendency for an advantage of the monthly regimen only in the first quarter of treatment.
Keyphrases
  • cross sectional
  • combination therapy
  • double blind